ReviewBrain pathology (Zurich, Switzerland)1999
Tau and synuclein and their role in neuropathology.
Review in Brain pathology (Zurich, Switzerland), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics.Pharmaceutics · 2024Review
- Structural insights into the unique recognition module between α-synuclein peptide and nanobody.Protein science : a publication of the Protein Society · 2024Article
- Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment.Brain, behavior, and immunity · 2019Article
- Acetylation Disfavors Tau Phase Separation.International journal of molecular sciences · 2018Article
- An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.The Journal of biological chemistry · 2017Article
- Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia.Neurobiology of aging · 2014Article
- Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.Human molecular genetics · 2014Article
- Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.Sleep medicine · 2013Article
- Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation.Human molecular genetics · 2012Article
- An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.Journal of neurology, neurosurgery, and psychiatry · 2012Article
- RETRACTED: Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.Molecular and cellular neurosciences · 2012Article
- Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases.International journal of Alzheimer's disease · 2012Article
- Inflammation in the early stages of neurodegenerative pathology.Journal of neuroimmunology · 2011Review
- Association of the MAPT locus with Parkinson's disease.European journal of neurology · 2010Article
- The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases.Frontiers in psychiatry · 2010Article
- Versatile somatic gene transfer for modeling neurodegenerative diseases.Neurotoxicity research · 2009Review
- Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2009Article
- Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.Acta neuropathologica · 2008Article
- Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.The European journal of neuroscience · 2008Article
- Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model.Neuroscience letters · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.